Vanguard Group Inc. Purchases 45,071 Shares of CorVel Corp. $CRVL

Vanguard Group Inc. raised its position in shares of CorVel Corp. (NASDAQ:CRVL) by 1.4% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,287,788 shares of the business services provider’s stock after purchasing an additional 45,071 shares during the quarter. Vanguard Group Inc. owned 6.41% of CorVel worth $254,541,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the stock. Federated Hermes Inc. raised its stake in CorVel by 147.4% during the 3rd quarter. Federated Hermes Inc. now owns 381 shares of the business services provider’s stock worth $29,000 after acquiring an additional 227 shares during the period. Hantz Financial Services Inc. purchased a new position in shares of CorVel during the 2nd quarter valued at $32,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new position in CorVel in the 2nd quarter worth $37,000. Asset Management One Co. Ltd. purchased a new stake in CorVel in the 3rd quarter worth $47,000. Finally, Quent Capital LLC bought a new stake in CorVel during the third quarter valued at about $87,000. 51.36% of the stock is owned by institutional investors.

CorVel Stock Down 0.7%

Shares of NASDAQ:CRVL opened at $51.58 on Friday. CorVel Corp. has a 52 week low of $44.83 and a 52 week high of $119.57. The firm has a 50 day moving average of $61.44 and a 200 day moving average of $72.02. The company has a market capitalization of $2.64 billion, a price-to-earnings ratio of 25.28 and a beta of 1.06.

CorVel (NASDAQ:CRVL) last announced its earnings results on Tuesday, February 3rd. The business services provider reported $0.47 earnings per share for the quarter. The company had revenue of $235.63 million during the quarter. CorVel had a net margin of 11.23% and a return on equity of 30.15%.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on CRVL shares. Weiss Ratings reissued a “hold (c)” rating on shares of CorVel in a research note on Friday, January 9th. Wall Street Zen cut shares of CorVel from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, CorVel presently has an average rating of “Hold”.

CorVel Profile

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).